INTRODUCTION
The pyruvate dehydrogenase complex (PDC) catalyses the oxidative decarboxylation of pyruvate to acetyl-CoA and CO2 and is one of the most extensively studied multi-enzyme systems (for recent reviews, see [1] [2] [3] ). It consists of multiple copies of three component enzymes, namely pyruvate dehydrogenase (Elp), dihydrolipoamide acetyltransferase (E2p) and lipoamide dehydrogenase (E3), which catalyse consecutive steps in the overall reaction.
Research on PDC has concentrated mainly on the E2p component, which has a central role in both the catalytic activity and the structure and assembly of the complex. The mammalian complex comprises a pentagonal dodecahedron core of 60 E2p subunits around which the Elp and E3 components are assembled: approx. 30 Elp tetramers (Oc2/2) bind at the 30 edges, and at least six E3 dimers on the 12 faces of the core [4] . The E2p component also has multiple roles in catalysis. It contains two covalently bound lipoyl cofactors that are reductively acetylated by Elp, the acetyl group then being transferred to CoA at the E2p active site. After acetyl transfer, the reduced lipoamide is reoxidized by E3 to complete the catalytic cycle. Thus the E2p carries determinants for the assembly of the E2p core, the specific binding of Elp and E3, the covalent attachment of lipoic acid and the acetyltransferase active site. Analysis of the cDNA sequence of various mammalian E2p subunits [5] [6] [7] [8] has confirmed earlier studies on the Escherichia coli enzyme [9, 10] that the E2p is highly segmented (see Figure 1 below). Two highly conserved lipoyl domains are located in tandem repeat at the N-terminus of the protein, foilowed by a distinct region of polypeptide considered to be involved in binding of the E3 component, although the mammalian complexes contain an additional component, protein X, which appears to play a major role in binding of E3 [11, 12] . The C-terminal catalytic domain of E2p, in addition to containing the active site, binds to other E2p polypeptides to been purified, corresponding to lipoylated and non-lipoylated species. The apo-domain can be lipoylated in vitro with partially purified E. coli lipoate protein ligase, and the lipoylated domain can be reductively acetylated by human Elp (pyruvate dehydrogenase). Availability of the two forms will now allow detailed biochemical and structural studies of the human lipoyl domains. maintain the central core, and is thought to be responsible for binding of the El component of the complex. These independent domains are interconnected by flexible linker regions, characteristically rich in alanine and proline residues.
The lipoyl domains of E2p are of considerable interest. It is the lipoate-lysine residue of these domains that is central to the activity of the complex, providing a swinging arm that has sufficient rotational mobility to allow movement between the active sites of the three component enzymes [13] . However, surprisingly little is known concerning the enzymes responsible for the attachment and removal of this essential lipoic acid cofactor. The sequence surrounding the lipoate-attachment site on several bacterial and mammalian PDCs has been determined [14] [15] [16] and is highly conserved. Individual lipoyl domains of E. coli and Bacillus stearothermophilus E2p have previously been over-expressed in E. coli, and both lipoylated and unlipoylated gene products were recovered [17] [18] [19] . Additionally octanoylation of the B. stearothermophilus and E. coli domains was observed, the latter when a lipoic acid-deficient mutant of E. coli was used as the host strain [20] . A recent study has provided evidence for two protein ligase activities in E. coli [21] . However, the only information on the mammalian lipoylation system, to date, is its intra-mitochondrial localization [22] .
Recently, considerable interest has been generated by the identification of E2p as the major mitochondrial autoantigen in the human autoimmune liver disease primary biliary cirrhosis (PBC) [23, 24] . Furthermore, the major epitope of E2p has been localized to the lipoyl domains in two separate studies [25, 26] , and work with the E2p from E. coli has indicated that the lipoic acid cofactor plays a key role in the immune response [27] . Consequently these domains are of both biochemical and medical interest.
The cDNA encoding the entire human E2p has previously been cloned and sequenced [7] . To 
RESULTS
Lysates from ampicillin-resistant XL 1-Blue transformants, carrying plasmids pGEX-2T and pGLIP-2T, were subjected to SDS/ PAGE after a standard 4 h induction. Strains harbouring plasmids pGEX-2T and pGLIP-2T over-express polypeptides of Mr approx. 27 500 and 39000 respectively ( Figure 2 When samples of the purified preparation were subjected to non-denaturing PAGE, two components were identified ( Figure  3, inset) , indicating that two forms of domain are generated on over-expression of the sub-gene [17] . These two forms were designated Ulip and Llip to correspond to their upper and lower positions (slower and faster migration) on non-denaturing PAGE. The relative amounts of the domains Ulip and Llip were approx. 3:2 with pGLIP-2T cultures after a standard 4 h induction, as determined by quantitative densitometric analysis.
In order to resolve the two forms of the domain, the mixture was fractionated by chromatography on Mono Q, the elution profile being shown in Figure 3 . Two protein peaks were detected. Non-denaturing PAGE of the peak fractions indicated that the domain mixture had been resolved into single forms of the domain (Figure 3, inset) . The upper band (Ulip) was consistently eluted ahead of the lower domain (Llip), suggesting that Llip carries an overall slightly higher negative charge under the conditions employed. Electrospray m.s. of the Ulip domain preparation gave a single component with an Mr of 1 The domain preparation was fractionated on a Mono Q column, equilibrated with 10 mM ammonium acetate (see the Experimental section). An ammonium acetate gradient (0-0.3 M) eluted two major peaks which were analysed on 15% non-denaturing polyacrylamide gels (inset). The inset shows non-denaturing PAGE of the domain preparation before chromatography (m), protein peak a and protein peak b. Further evidence that Ulip and Llip correspond to the nonlipoylated and lipoylated forms of the domain was obtained by incubating Ulip with partially purified E. coli lipoate protein ligase. After a 6 h incubation with the lipoate ligase, the majority of Ulip was converted into Llip, as detected by its increased mobility on non-denaturing PAGE. This conversion was dependent on the presence of both ATP and lipoic acid (required for ligase activity), further indicating that it resulted from lipoylation of Ulip (Figure 4a ). When lipoylation of Ulip was carried out using [2-3H]lipoic acid, radioactivity was detected only in the Llip form (Figure 4b [17, 18] . Lipoylated and unlipoylated forms of the B. stearothermophilus lipoyl domain are likewise produced during expression in E. coli [19] . In this respect it is of interest that, when the E2 component of the ox liver branched-chain-2-oxo-acid dehydrogenase complex was expressed in E. coli, it was apparently unlipoylated [22] . However, incubation of the recombinant protein with ox liver mitochondrial extracts resulted in lipoylation of the E2. The lipoylation of the recombinant human domain is therefore the first report of correct post-translational modification in vivo of a eukaryotic substrate by the E. coli lipoylating system. Furthermore, the availability of large amounts of human unlipoylated domain, produced in the present study, will permit investigation of the mammalian lipoylation system and of the possible presence of a mammalian lipoamidase.
The ability to over-express and isolate different forms of the human lipoyl domain also offers opportunities for structure determination by two-dimensional 'H n.m.r. Previous structural studies on the PDC have been hindered by the large size of the complex and its components, resulting in little tertiarystructure data becoming available. A method of circumventing this problem, particularly with E2p, is by structural determination of the individual domains. The availability of homogeneous lipoyl domain from overexpression of the B. stearothermophilus subgene has made it possible to tackle the structure by n.m.r. spectroscopy. The 400 MHz 'H n.m.r. spectra of lipoylated and unlipoylated forms of the domain are essentially identical [17] . Furthermore the secondary structure of the B. stearothermophilus lipoyl domain has been determined [37] . Over-expression of the human domain will now permit similar studies on this protein.
The inner lipoyl domains of human E2p has been identified as the major auto-epitope in the autoimmune disease PBC (see above), although at present there is conflicting evidence as to whether lipoic acid is required for antigenicity. Investigations using the recombinant human E2p indicated that site-directed mutagenesis at the lipoate-lysine residue resulted in only minor differences in antibody recognition of the resulting proteins [38] . However, it was acknowledged in that study that the lipoylation state of the 'wild-type' recombinant protein was unknown. In contradiction to this, immunoblotting and e.l.i.s.a. studies on genetically engineered E. coli domains indicated that the presence of a lipoyl or octanoyl residue within the domain was crucial for antibody recognition [27] . The availability of both lipoylated and unlipoylated human antigen will help resolve this controversy and, more importantly, permit further studies into the role of the antigen in disease pathogenesis.
